Topamax Birth Defects

COMMON SIDE EFFECTS TOPAMAX | Fopamax 25 Fatigue Weight Loss Numbness 60 Comprimes Comprimidos SERIOUS SIDE EFFECTS BIRTH DEFECTS Birth defects such as: Cleft Lip and Palate Hypoplastic Left/Right Heart Syndrome Limb Malformations Persistent Pulmonary Hypertention Topamax (topiramate) is a drug used to treat epilepsy and to prevent migraines. It has also been used for off-label weight loss for many years and recently the FDA approved a combination of topiramate and phentermine for weight loss. In 1996, the FDA approved Topamax for manufacture and marketing by McNeil Pharmaceuticals and Janssen Pharmaceuticals, which are both owned by Johnson & Johnson. Since the drug's introduction to the market, Topamax has earned billions of dollars in sales but recently sales have been decreasing while birth defect lawsuits have been increasing. in Newborns (PPHN) Septal Heart Defects And Other Birth Defects Eye Problems Suicidal Thoughts 2008: A medical study found that cleft lip and cleft palate were 11 times more likely in newborns whose mothers had taken Topamax during pregnancy. The FDA reviewed Topamax adverse event reports and found 67 birth defects. Among these were 10 facial defects, 11 cleft lip/palate defects, 19 malformations, and 15 cardiovascular defects. 2012: The FDA approved a combination of topiramate and phentermine for weight loss. The FDA received 422 reports that Topamax had caused problems during pregnancy. In its annual report, Johnson & Johnson stated that there were at least 75 Topamax product liability lawsuits. 2010: Between 2007 and 2010, the FDA found that over 32 million Topamax prescriptions had been written to about 4.3 million patients. McNeil and Janssen paid $81 million because they had illegally marketed Topamax. 67 FDA 19 Malformations 422 REPORTS 75 LAWSUITS 15 Cardiovascular 32 MILLION BIRTH 12 Other 4.3 MILLION DEFECTS, 11 Cleft Lip/Palate 10 Facial $81 MILLION Call d'Oliveira & Associates at 1-800-992-6878 for a Free Consultation TIMELINE